Quick Answer
LIPELLA PHARMACEUTICALS INC. reported Total Revenue of $536.4 thousand for fiscal year 2024.
LIPELLA PHARMACEUTICALS INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $536.4K | +19.3% |
| 2023 | $449.6K | +144.2% |
| 2022 | $184.2K | -29.0% |
| 2021 | $259.3K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | $86.7K | -36.4% | -33.0% |
| March 31, 2025 | $129.4K | -11.3% | +61.0% |
| September 30, 2024 | $80.4K | -22.7% | -41.1% |
| June 30, 2024 | $136.4K | +27.9% | -6.5% |
| March 31, 2024 | $145.9K | +23.6% | +40.2% |
| September 30, 2023 | $104.1K | — | -2.5% |
| June 30, 2023 | $106.7K | — | -9.6% |
| March 31, 2023 | $118.0K | +256.1% | +256.1% |
- LIPELLA PHARMACEUTICALS INC. showed an increase of +19.3% in Total Revenue compared to the prior fiscal year.
- Over the 2021–2024 period, LIPELLA PHARMACEUTICALS INC.’s total revenue has grown by 106.8% (from $259.3 thousand to $536.4 thousand).
- The most recent figure is from LIPELLA PHARMACEUTICALS INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: